Normal View Dyslexic View
A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma.
17 May 2022
Randomized clinical trials Endocrine
Ahn J-H, Kwak JH, Yoon SG, Yi JW, Yu HW, Kwon H et al.
Surgery 2022; 171: 182-189.
Central lymph node dissection improved the yield of positive nodes in this study of 101 procedures, without affecting complication rates. No patient had a recurrence up to four years after surgery.
Published on: 17 May 2022
Article ID: rct215


.png)





.jpg)




